Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Melanoma 11Carcinoma, Renal Cell 8Neoplasm Metastasis 4Leukemia 4Triple Negative Breast Neoplasms 3Recurrence 3Pancreatic Neoplasms 2Neoplasms 2Multiple Myeloma 2Lymphoma 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Kidney Neoplasms 2Hematologic Neoplasms 2Colorectal Neoplasms 2Breast Neoplasms 2Brain Neoplasms 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Thrombocythemia, Essential 1Skin Neoplasms 1Prostatic Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Polycythemia Vera 1Peritoneal Neoplasms 1

Interventions

Peripheral Blood Stem Cell Transplantation 36fludarabine phosphate 33Cyclophosphamide 31Mycophenolic Acid 26Whole-Body Irradiation 23Tacrolimus 22Cyclosporine 19Radiotherapy 16Busulfan 16Antilymphocyte Serum 15Methotrexate 14Filgrastim 12Etoposide 12Flow Cytometry 11Rituximab 8Methylprednisolone 8Melphalan 8Brentuximab Vedotin 8pembrolizumab 7Therapeutics 7Lenalidomide 7Bortezomib 7Psychiatric Rehabilitation 6Gemcitabine 6Cord Blood Stem Cell Transplantation 6Bexarotene 6romidepsin 5mogamulizumab 5fludarabine 5Transplantation 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Mycosis Fungoides × Interferon alpha-2 × Clear all
NCT00038376 2018-10-29

Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies

M.D. Anderson Cancer Center

Phase 2 Completed
56 enrolled
LymphoidOther hematologic neoplasm

Mycosis Fungoides, Lymphoma, T-Cell, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡